Csl Limited Stock Beta
| CMXHF Stock | USD 176.00 2.75 1.59% |
CSL Limited fundamentals help investors to digest information that contributes to CSL's financial success or failures. It also enables traders to predict the movement of CSL Pink Sheet. The fundamental analysis module provides a way to measure CSL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CSL pink sheet.
CSL |
CSL Limited Company Beta Analysis
CSL's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current CSL Beta | 0.19 |
Most of CSL's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CSL Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, CSL Limited has a Beta of 0.1881. This is 78.13% lower than that of the Healthcare sector and 86.47% lower than that of the Biotechnology industry. The beta for all United States stocks is notably lower than that of the firm.
CSL Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CSL's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CSL could also be used in its relative valuation, which is a method of valuing CSL by comparing valuation metrics of similar companies.CSL is currently under evaluation in beta category among related companies.
As returns on the market increase, CSL's returns are expected to increase less than the market. However, during the bear market, the loss of holding CSL is expected to be smaller as well.
CSL Fundamentals
| Return On Equity | 0.2 | |||
| Return On Asset | 0.0798 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 96.65 B | |||
| Shares Outstanding | 482.22 M | |||
| Shares Owned By Insiders | 0.41 % | |||
| Shares Owned By Institutions | 35.50 % | |||
| Price To Earning | 33.44 X | |||
| Price To Book | 6.65 X | |||
| Price To Sales | 9.30 X | |||
| Revenue | 10.49 B | |||
| Gross Profit | 5.73 B | |||
| EBITDA | 3.46 B | |||
| Net Income | 2.25 B | |||
| Cash And Equivalents | 10.44 B | |||
| Cash Per Share | 21.67 X | |||
| Total Debt | 3.86 B | |||
| Debt To Equity | 0.66 % | |||
| Current Ratio | 2.32 X | |||
| Book Value Per Share | 30.26 X | |||
| Cash Flow From Operations | 2.63 B | |||
| Earnings Per Share | 4.80 X | |||
| Number Of Employees | 30 K | |||
| Beta | 0.19 | |||
| Market Capitalization | 102.75 B | |||
| Total Asset | 28.35 B | |||
| Retained Earnings | 6.59 B | |||
| Working Capital | 2.44 B | |||
| Current Asset | 3.82 B | |||
| Current Liabilities | 1.37 B | |||
| Z Score | 15.6 | |||
| Annual Yield | 0.01 % | |||
| Five Year Return | 1.08 % | |||
| Net Asset | 28.35 B | |||
| Last Dividend Paid | 2.22 |
About CSL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CSL Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CSL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CSL Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with CSL
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CSL position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CSL will appreciate offsetting losses from the drop in the long position's value.Moving together with CSL Pink Sheet
| 0.88 | CSLLY | CSL | PairCorr |
| 0.61 | VRTX | Vertex Pharmaceuticals Financial Report 6th of May 2024 | PairCorr |
Moving against CSL Pink Sheet
| 0.58 | WMT | Walmart Financial Report 16th of May 2024 | PairCorr |
| 0.57 | SGEN | Seagen Inc Earnings Call Tomorrow | PairCorr |
| 0.5 | TSM | Taiwan Semiconductor Financial Report 18th of July 2024 | PairCorr |
| 0.49 | NVO | Novo Nordisk AS Financial Report 2nd of May 2024 | PairCorr |
| 0.47 | NONOF | Novo Nordisk AS | PairCorr |
The ability to find closely correlated positions to CSL could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CSL when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CSL - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CSL Limited to buy it.
The correlation of CSL is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CSL moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CSL Limited moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CSL can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CSL Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the CSL Limited information on this page should be used as a complementary analysis to other CSL's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for CSL Pink Sheet analysis
When running CSL's price analysis, check to measure CSL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CSL is operating at the current time. Most of CSL's value examination focuses on studying past and present price action to predict the probability of CSL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CSL's price. Additionally, you may evaluate how the addition of CSL to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |